Dennis Cho, Senior Vice President, Chief Legal Officer and Corporate Secretary of Twist Bioscience Corp (NASDAQ:TWST), filed a Form 4 on September 10, 2026, reporting a sale of 412 shares of common stock on September 8, 2026, to cover tax withholding obligations tied to vesting restricted stock units.

Key Highlights

  • Transaction date: 412 shares of Twist Bioscience Corp common stock were disposed of on September 8, 2026.
  • Sale price: Shares were sold at $122.624 per share.
  • Purpose: The filing states the shares were sold to cover tax withholding obligations connected to the vesting of restricted stock units, under a "sell to cover" arrangement mandated by the issuer.
  • Remaining ownership: Following the transaction, Dennis Cho directly beneficially owned 73,651 shares of common stock.
  • Non-discretionary: According to the filing, the sales "do not represent discretionary trades by the Reporting Person."
  • Signatory: The form was signed by Kendra Fox as Attorney-in-Fact for Dennis Cho on September 10, 2026.

Dennis Cho's RSU Vesting Triggers Mandatory Share Sale at Twist Bioscience

According to the Form 4 filed with the SEC on September 10, 2026, Dennis Cho, who serves as Senior Vice President, Chief Legal Officer and Corporate Secretary at Twist Bioscience Corp, disposed of 412 shares of the company's common stock on September 8, 2026. The shares were sold at a price of $122.624 each, using transaction code "S," indicating an open-market sale.

The filing explains that the sale was not a discretionary decision by Cho. As footnote 1 states, it "represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units." The filing further notes that "these sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a 'sell to cover' transaction." No transaction activity was reported in Table II covering derivative securities.

Following the reported transaction, Cho's direct beneficial ownership of Twist Bioscience Corp common stock stood at 73,651 shares, as disclosed in Table I of the filing. The form was filed by one reporting person and covers a single transaction in non-derivative securities.

What Was Disclosed

Dennis Cho, an officer of Twist Bioscience Corp, reported a mandatory sale of 412 common shares at $122.624 per share on September 8, 2026, to satisfy tax withholding requirements from RSU vesting, leaving him with 73,651 shares directly owned.